Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...
BACKGROUND: This trial aimed to test the effectiveness of a data-driven quality improvement program in primary care on ...
Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial ...
A controlled trial examines how different protein choices influence metabolic health, offering new insight into diet and ...
Objective To investigate whether aligning exercise timing with chronotype enhances cardiometabolic and sleep-related benefits ...
Introduction Poor adherence to risk factor control and life-saving medications is a key factor affecting long-term patient ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results